Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$727M |
| 2 |
Home Depot
HD
|
+$472M |
| 3 |
Pfizer
PFE
|
+$362M |
| 4 |
Texas Instruments
TXN
|
+$314M |
| 5 |
LyondellBasell Industries
LYB
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$567M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$245M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$242M |
| 4 |
AT&T
T
|
+$170M |
| 5 |
Accenture
ACN
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
HireQuest
HQI
$198M
| $286K | ﹤0.01% |
14,916
+4,120
| +38% | +$75.6K |
|
3227
Remitly
RELY
$5.05B
| $283K | ﹤0.01% |
28,657
+2,081
| +8% | +$24.8K |
|
3228
VirnetX Holding Corp
VHC
$56.8M
| $281K | ﹤0.01% |
8,610
+500
| +6% | +$20.4K |
|
3229
Ardelyx
ARDX
$1.23B
| $278K | ﹤0.01% |
259,422
| – | – |
|
3230
Crawford & Co Class A
CRD.A
$552M
| $278K | ﹤0.01% |
36,725
-9,120
| -20% | -$69.2K |
|
3231
Willis Lease Finance
WLFC
$1.74B
| $278K | ﹤0.01% |
25,887
+5,865
| +29% | +$67.9K |
|
|
SURF
3232
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $278K | ﹤0.01% |
94,404
+6,450
| +7% | +$22.6K |
|
3233
PubMatic
PUBM
$602M
| $277K | ﹤0.01% |
10,574
| – | – |
|
3234
Victory Capital Holdings
VCTR
$6.49B
| $277K | ﹤0.01% |
9,585
+2,728
| +40% | +$89.1K |
|
|
FNCH
3235
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $277K | ﹤0.01% |
1,832
-92
| -5% | -$21.2K |
|
|
PLM
3236
DELISTED
PolyMet Mining Corp.
PLM
| $277K | ﹤0.01% |
66,038
+4,854
| +8% | +$13.9K |
|
3237
AquaBounty Technologies
AQB
$4.73M
| $276K | ﹤0.01% |
7,362
+749
| +11% | +$26K |
|
3238
Canadian National Railway
CNI
$76.1B
| $272K | ﹤0.01% |
+2,024
| New | +$253K |
|
3239
Fortress Biotech
FBIO
$91.7M
| $272K | ﹤0.01% |
13,298
+864
| +7% | +$23.7K |
|
3240
Verrica Pharmaceuticals
VRCA
$90.2M
| $272K | ﹤0.01% |
3,345
| – | – |
|
|
USX
3241
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $270K | ﹤0.01% |
69,332
| – | – |
|
|
INFI
3242
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $269K | ﹤0.01% |
235,240
+19,790
| +9% | +$23.6K |
|
|
ICAD
3243
DELISTED
iCAD Inc
ICAD
| $268K | ﹤0.01% |
60,038
+4,253
| +8% | +$21.4K |
|
|
LSEA
3244
DELISTED
Landsea Homes
LSEA
| $268K | ﹤0.01% |
31,311
+6,542
| +26% | +$48.7K |
|
3245
LSB Industries
LXU
$707M
| $268K | ﹤0.01% |
12,230
-3,294
| -21% | -$48.6K |
|
3246
Aligos Therapeutics
ALGS
$28.5M
| $267K | ﹤0.01% |
4,953
-610
| -11% | -$48.8K |
|
3247
Werewolf Therapeutics
HOWL
$17.9M
| $267K | ﹤0.01% |
60,646
+52
| +0.1% | +$364 |
|
|
HARP
3248
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $267K | ﹤0.01% |
5,360
+372
| +7% | +$19.3K |
|
3249
HighPeak Energy
HPK
$888M
| $266K | ﹤0.01% |
11,965
+1,404
| +13% | +$27.6K |
|
|
TRVN
3250
DELISTED
Trevena, Inc.
TRVN
| $266K | ﹤0.01% |
772
+67
| +10% | +$21.1K |
|
Similar funds
Charles Schwab's Q1 2022 Portfolio in Review
As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.
- Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
- Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
- Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
- Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
- Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
- Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.
Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.